http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Cancer survivors who had chest radiation are nearly twice as likely to die in the years after having major heart surgery as similar patients who didn't have radiation, according to research in the American Heart Association journal Circulation. http://medicalxpress.com/news/2013-04-heart-surgery-death-cancer-survivors.html Cardiology Mon, 08 Apr 2013 16:00:03 EST news284644712 (Medical Xpress)—A team of researchers at Indiana University's School of Medicine has found that giving meloxicam, a non-steroidal anti-inflammatory drug (NSAID), to people and baboons boosts the number of haematopoietic stem cells that enter the blood stream from bone marrow. This, the team writes in their paper they've had published in the journal Nature, may help cancer patients recover their ability to create new blood cells following chemotherapy. http://medicalxpress.com/news/2013-03-nsaids-stem-cells-bloodstream-prior.html Medical research Thu, 14 Mar 2013 08:37:33 EST news282469042 Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell – DLBCL (ABC-DLBCL), remains a major therapeutic challenge. An international research team, led by two laboratories from Weill Cornell Medical College, has developed a new experimental drug therapy to target this aggressive form of lymphoma. http://medicalxpress.com/news/2012-12-drug-therapy-aggressive-non-hodgkin-lymphoma.html Cancer Mon, 10 Dec 2012 15:46:52 EST news274376793 A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time. The findings will be published in the November issue of Cancer Research. http://medicalxpress.com/news/2012-11-scientists-lung-cancer-treatment.html Cancer Thu, 01 Nov 2012 15:11:39 EST news271001442 (Medical Xpress)—Two groups of researchers have published articles in the journal Biology Letters, suggesting that it's time we stop blaming cats for making people crazy or for a certain type of brain cancer that other researchers have linked to a parasite in cat feces. The first group, with the Tour du Valat research center, say that after looking at all the current research findings they can find no evidence linking cats and brain cancer in people. The second team from Oxford University's Cancer Epidemiology Unit, after conducting what they call the "Million Woman Survey" have found among many other things, that there was no more incidence of brain cancer in women who owned cats than in those who did not. http://medicalxpress.com/news/2012-08-blaming-cats-brain-cancer-people.html Cancer Thu, 23 Aug 2012 08:44:58 EST news264930265 (HealthDay) -- For children with Hodgkin's lymphoma who respond to chemotherapy, treatment with low-dose involved-field radiation therapy (IFRT) improves event-free survival (EFS), but has no significant impact on overall survival (OS), in long-term follow-up, according to a study published online May 29 in the Journal of Clinical Oncology. http://medicalxpress.com/news/2012-05-ups-event-free-survival-ped-hodgkin.html Cancer Thu, 31 May 2012 18:50:01 EST news257707104 A study published Online First by The Lancet has found that patients with advanced Hodgkin's lymphoma (a cancer affecting lymph tissue) can be treated more effectively with lower doses of chemotherapy. The study is by Dr Andreas Engert, University Hospital of Cologne, Germany, and colleagues. http://medicalxpress.com/news/2012-04-intense-chemotherapy-effective-toxic-patients.html Cancer Tue, 03 Apr 2012 18:30:02 EST news252689507 High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy alone, according to an online study published December 21 in the Journal of the National Cancer Institute. http://medicalxpress.com/news/2011-12-autologous-stem-cell-transplantation-os.html Cancer Wed, 21 Dec 2011 16:00:01 EST news243694806 Positron emission tomography (PET) and a molecular imaging agent that captures the proliferation of cancer cells could prove to be a valuable method for imaging a form of Non-Hodgkin's disease called mantle cell lymphoma, a relatively rare and devastating blood cancer. The pilot study is published in the December issue of the Journal of Nuclear Medicine. http://medicalxpress.com/news/2011-12-pet-technique-response-non-hodgkin-lymphoma.html Cancer Wed, 21 Dec 2011 12:31:44 EST news243693083 An experimental vaccine developed by researchers at the University of Pennsylvania's schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for dogs with spontaneous non-Hodgkin's lymphoma. The work shows for the first time the feasibility and therapeutic efficacy of this alternative cell-based vaccine, which could be employed in the treatment of a number of different cancer types. http://medicalxpress.com/news/2011-10-efficacy-non-hodgkin-lymphoma-vaccine.html Cancer Tue, 18 Oct 2011 15:26:35 EST news238170373 Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy. http://medicalxpress.com/news/2011-06-lab-clinic-therapy-blood-cancers.html Cancer Thu, 02 Jun 2011 17:24:01 EST news226254213 In a significant breakthrough, investigators at Weill Cornell Medical College and the University of California, San Francisco, have been able to overcome resistance of a form of leukemia to targeted therapy, demonstrating complete eradication of the cancer in cell and animal studies. http://medicalxpress.com/news/2011-05-drug-aggressive-childhood-leukemia.html Cancer Tue, 24 May 2011 15:45:47 EST news225470713